Neonatal treatment with leptin, from P3 to P13, can also reduce the hyperleptinemia, hyperinsulinemia, hyperphagia, and obesity associated with in utero growth restriction and subsequent high fat diet, albeit with some sex differences (Vickers et al., 2005, 2008). The gene discussed is LEP; the disease is obesity disorder.